JPRN-UMIN000030916已完成未知
The evaluation of bone mineral density in long-term survival patients after allogeneic hematopoietic stem cell transplantation: cross sectional study by KSGCT - The evaluation of bone mineral density in long-term survival patients after allogeneic hematopoietic stem cell transplantation: KSGCT1701(Bone-Dx)
Kanto Study Group for Cell Therapy0 个研究点目标入组 350 人开始时间: 2018年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 99years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who are otherwise classified as unfit by the attending physicians for this research. 2) Patients who underwent allogeneic and/or autologous transplantation more than once 3) Patients with multiple myeloma
研究者
相似试验
已完成
不适用
ong-term observation on adult bone mineral density and lifestyle-related diseases prevention with daily lemon intake in Osakikamijima Town, Hiroshima prefectureJPRN-UMIN000025818SAPPORO HOLDINGS Ltd.170
招募中
不适用
Evaluation of bone mineral density and bone metabolism during treatment with the januskinaseinhibitor upadacitinib in patients with rheumatoid arthritisDRKS00021182Campus Kerckhoff der Jusuts-Liebig-Universität Gießen, Abteilung für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin60
已完成
不适用
Evaluation of bone mineral density and bone metabolism during treatment with januskinaseinhibitors baricitinib or tofacintib in patients with rheumatoid arthritisM05.80M06.00DRKS00020780Campus Kerckhoff der Justus Liebig Universität Giessen, Abteiliung für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin89
招募中
不适用
Study of bone mineral density and renal function in cured patients of hyperparathyroidism.CTRI/2019/05/019365Department of Endocrinology
进行中（未招募）
1 期
ong-term bone mineral density follow-up in subjects completing PRIMROSE 1 or PRIMROSE 2Treatment of heavy menstrual bleeding associated with uterine fibroids.MedDRA version: 21.1Level: LLTClassification code 10046784Term: Uterine fibroidsSystem Organ Class: 100000004864EUCTR2021-000452-19-BGObsEva S.A.400